JBIO
Jade Biosciences, Inc.
16.80$
+0.1%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.2% | 99.4% | 97.2% | 97.5% | 99.7% | 96.1% | |
| 97.0% | 30.9% | 16.6% | 18.4% | 42.0% | 25.3% | |
| 97.0% | 95.4% | 95.5% | 96.1% | 97.9% | 96.1% | |
| 37.6% | 1.7% | 6.3% | 14.1% | 4.9% | 4.9% | |
| 37.6% | 1.5% | 5.8% | 13.8% | 4.8% | 4.7% | |
| – | 0.1% | 0.3% | 0.3% | 0.5% | – | |
| 13.1% | 0.7% | 1.9% | 1.9% | 0.3% | 0.6% | |
| – | – | – | – | 133.9% | – | |
| 62.4% | 98.3% | 93.7% | 85.9% | 95.1% | 95.1% | |
| -284.3% | -20.8% | -65.0% | -128.3% | -290.1% | -49.9% | |
| 14.8% | 0.4% | 0.5% | 0.6% | 1.0% | 9.0% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.